Effect of L-arginine oral supplementation on response to myocardial infarction in hypercholesterolemic and hypertensive rats

Plant Foods for Human Nutrition

Volumn 65, Issue 1, 2010, Pages 31-37

  Piñeiro, Verónica ^a   Ortiz Moreno, Alicia ^a   Mora Escobedo, Rosalva ^a   Hernández Navarro, María Dolores ^b   Ceballos Reyes, Guillermo ^a   Chamorro Cevallos, Germán ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

Cholesterol; Dyslipidemia; Hypercholesterolemia; Hypertension; Ischemia reperfusion; L arginine

Indexed keywords

ARGININE; CARDIOVASCULAR AGENT; NITRIC OXIDE;

ANIMAL; ARTICLE; BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ADMINISTRATION, ORAL; ANIMALS; ARGININE; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; DIETARY SUPPLEMENTS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 77949571197     PISSN: 09219668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11130-009-0143-y     Document Type: Article

References (24)

1. Teixeira de Almeida D, Santaolaria Ayora ML, Alonso Iglesias E (2003) La arginina en su contexto metabólico y fisiológico. Acta Bioquim Clin Latinoam 37: 165-179.
2. Bryan N, Calvert J, Elrod J, Gundewar S, Yong S, Lefer D (2007) Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Pharmacology 48: 19104-19149.
3. Wu G, Meininger C (2000) Arginine nutrition and cardiovascular function. J Nutr 130: 2626-2629.
4. Wu G, Morris S (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17.
5. Maxwell A, Zapien M, Pearce G, MacCallum G, Stone P (2002) Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol 39: 37-45.
6. Creager M, Gallagher S, Girerd X, Dzau V, Cooke J (1992) L-arginine improves endothelium-dependent vasodilatation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253.
7. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang P (2003) Effects of chronic treatment with L-arginine on atherosclerosis in ApoE knockout and ApoE/Inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol 23: 97-103.
8. Loscalzo J (2003) Adverse effects of supplemental L-arginine in atherosclerosis. Consequences of methylation stress in a complex catabolism. Arterioscler Thromb Vasc Biol 23: 3-5.
9. Ignarro L, Cirino G, Casini A (1999) Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovascular Pharmacol 34: 879-886.
10. Gouvêa SA, Moysés MR, Bissoli NS, Pires JGP, Cabral AM, Abreu GR (2003) Oral administration of L-arginine decreases blood pressure and increases renal excretion of sodium and water in renovascular hypertensive rats. Braz J Med Biol Res 36: 943-949.
11. Dumont Y, D'Amours M, Lebel M, Larivière R (2001) Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol Transplant 16: 746-754.
12. Chang HR, Lee RP, Wu CY, Chen HI (2002) Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin Exp Pharmacol Physiol 29: 275-280.
13. Ferdinandy P, Schulz R (2003) Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138: 532-543.
14. Webb A, Bonnd R, Mc Lean P, Uppal R, Benjamin N, Ahluwalia A (2004) Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Pharmacology 37-101: 13683-13688.
15. Duranski MR, Greer JJM, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115: 1232-1240.
16. Norma Oficial Mexicana-062-ZOO-1999. Especificaciones Técnicas para la producción, cuidado y uso de los animales de laboratorio. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación. Estados Unidos Mexicanos.
17. Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H, Kimura H (1986) Effects of crude drugs on experimental hypercholesterolemia. Tea and its active principles. J Ethnopharmacol 17: 213-224.
18. Zulet MA, Barber A, Garcin H, Higueret P, Martínez JA (1999) Alterations in carbohydrate and lipid metabolism induced by a diet rich in coconut oil and cholesterol in a rat model. J Am Coll Nutr 18(1): 36-42.
19. Downey J (2003) Measuring infarct size by the tetrazolium method. Available from: http://www. usouthal. edu/ishr/help/ttc/.
20. Tallarida RJ, Murray RB (1987) Manual of pharmacological calculations. Springer Verlag, New York, p 131.
21. Böger RH, Bode-Roger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC (1995) Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 117: 273-284.
22. Boger RH, Bode-Roger SM, Phivthong-ngam L, Brandes RP, Schwedhel E, Mugge A, Bohme M, Tsikas D, Frolich JC (1997) Dieray L-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 141: 31-43.
23. Böger RH, Bode-Böger SM, Thiele W, Creutzing A, Alexander K, Frölich JC (1998) Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 32: 1336-1344.
24. Kawano T, Nomura M, Nisikado A, Nakaya Y, Ito S (2003) Supplementation of L-arginine improves hypertension and lipids metabolism but not insulin resistance in diabetic rats. Life Sci 73: 3017-3026.